Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$601M |
| 2 |
Gilead Sciences
GILD
|
+$574M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
Altria Group
MO
|
+$370M |
| 5 |
WIX.com
WIX
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$581M |
| 2 |
eBay
EBAY
|
+$465M |
| 3 |
Lam Research
LRCX
|
+$300M |
| 4 |
Becton Dickinson
BDX
|
+$267M |
| 5 |
UnitedHealth
UNH
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.08% |
| 2 | Financials | 11.82% |
| 3 | Industrials | 8.17% |
| 4 | Healthcare | 7.52% |
| 5 | Consumer Discretionary | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3851
CEMIG Preferred Shares
CIG
$6.12B
| $55.1K | ﹤0.01% |
27,787
| – | – |
|
|
MKZR
3852
MacKenzie Realty Capital
MKZR
$3.45M
| $53.7K | ﹤0.01% |
8,022
| – | – |
|
3853
Vuzix
VUZI
$213M
| $50.5K | ﹤0.01% |
17,300
-500
| -3% | -$1.18K |
|
3854
Cipher Digital
CIFR
$7.65B
| $48.2K | ﹤0.01% |
10,085
-9,263
| -48% | -$30K |
|
3855
MannKind Corp
MNKD
$1.27B
| $44K | ﹤0.01% |
11,755
-38,147
| -76% | -$168K |
|
3856
Ardelyx
ARDX
$1.21B
| $41.1K | ﹤0.01% |
10,483
-36,237
| -78% | -$149K |
|
3857
1stdibs.com
DIBS
$174M
| $37.3K | ﹤0.01% |
13,567
-673
| -5% | -$1.74K |
|
|
ORGN
3858
DELISTED
Origin Materials
ORGN
| $36.4K | ﹤0.01% |
2,513
+1,329
| +112% | +$22.5K |
|
3859
Arbutus Biopharma
ABUS
$913M
| $35.4K | ﹤0.01% |
11,440
-7,361
| -39% | -$24.4K |
|
3860
Ironwood Pharmaceuticals
IRWD
$683M
| $34.5K | ﹤0.01% |
48,127
-1,494
| -3% | -$1.17K |
|
3861
Veritone
VERI
$112M
| $31.1K | ﹤0.01% |
24,680
-406
| -2% | -$737 |
|
3862
Ambev
ABEV
$46.8B
| $30.8K | ﹤0.01% |
12,766
+1,911
| +18% | +$4.65K |
|
3863
Alto Neuroscience
ANRO
$1.09B
| $29.9K | ﹤0.01% |
13,582
-1,687
| -11% | -$4.01K |
|
3864
CBAK Energy Technology Ltd
CBAT
$43.9M
| $23.6K | ﹤0.01% |
19,999
| – | – |
|
3865
Gold Royalty Corp
GROY
$667M
| $22.1K | ﹤0.01% |
10,000
| – | – |
|
3866
Lineage Cell Therapeutics
LCTX
$284M
| $21.3K | ﹤0.01% |
23,500
-23,397
| -50% | -$13.9K |
|
3867
Snail Inc
SNAL
$37.1M
| $20K | ﹤0.01% |
2,920
-100
| -3% | -$527 |
|
3868
Alector
ALEC
$165M
| $19.8K | ﹤0.01% |
14,135
+3,449
| +32% | +$4.32K |
|
3869
Tilray
TLRY
$602M
| $19.2K | ﹤0.01% |
4,625
-1,026
| -18% | -$4.66K |
|
3870
Oxbridge Re Holdings
OXBR
$12.6M
| $17.4K | ﹤0.01% |
10,000
| – | – |
|
3871
Wolfspeed
WOLF
$1.31B
| $13.1K | ﹤0.01% |
32,782
-351,322
| -91% | -$801K |
|
|
MPTI.WS
3872
DELISTED
M-tron Industries Warrants
MPTI.WS
| $11.2K | ﹤0.01% |
+10,778
| New | +$12.3K |
|
3873
GrowGeneration
GRWG
$88.9M
| $11K | ﹤0.01% |
11,722
-525
| -4% | -$560 |
|
3874
ChargePoint
CHPT
$150M
| $10.7K | ﹤0.01% |
762
-1,679
| -69% | -$22.5K |
|
3875
Retractable Technologies
RVP
$20.1M
| $9.21K | ﹤0.01% |
14,400
-1,000
| -6% | -$696 |
|
Similar funds
Ameriprise's Q2 2025 Portfolio in Review
As of Q2 2025, Ameriprise held 4,177 positions worth $406B, up 9.5% from $370B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Ameriprise's Q2 2025 filing shows 166 new, 1,840 increased, 1,831 reduced and 222 closed positions. Its largest new stake was JPMorgan Mortgage-Backed Securities ETF: 3,498,838 shares worth $176M. The largest sale was AbbVie, an estimated $581M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Industrials.
- Ameriprise's largest Q2 2025 buy was JPMorgan Mortgage-Backed Securities ETF: 3,498,838 shares worth $176M.
- Ameriprise added most to Alphabet (Google) Class A in Q2 2025, an estimated $601M increase.
- Ameriprise's biggest Q2 2025 reduction was AbbVie, cutting an estimated $581M.
- Ameriprise fully exited Discover Financial Services in Q2 2025, selling an estimated $111M.
- Ameriprise's ten largest holdings make up 21% of its $406B portfolio in Q2 2025.
- Ameriprise opened 166 new positions and closed 222 in Q2 2025.
- Ameriprise's portfolio value rose 9.5% quarter-over-quarter to $406B.
Based on Ameriprise's 13F filing for Q2 2025, filed 14 Aug 2025.